INBP
INTEGRATED BIOPHARMA INC
Key Financials
Operating Income
$2.0M
↑ 704.8%
Net Income
$808000
↑ 621.4%
Gross Profit
$5.6M
↑ 43.2%
Revenue
$43.7M
↓ 6.9%
EPS (Diluted)
$0.03
↑ Infinity%
Total Liabilities
$4.6M
↓ 34.2%
Total Assets
$24.9M
↓ 5.0%
Shareholders' Equity
$20.3M
↑ 5.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INBP |
| Company Name | INTEGRATED BIOPHARMA INC |
| CIK | 1016504 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 9739260816 |